Richmond, VA, United States of America

Koushambi Mitra


 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Koushambi Mitra

Introduction

Koushambi Mitra is an innovative inventor based in Richmond, VA (US). He has made significant contributions to the field of cancer treatment through his research and development of novel therapeutic agents. His work focuses on the use of near-infrared activatable fluorescent small molecules, which have the potential to revolutionize cancer therapy.

Latest Patents

Koushambi Mitra holds a patent for "Near-IR activatable fluorescent small molecules with dual modes of cytotoxicity." This patent describes a method for the photodynamic treatment of cancer using near-infrared activatable fluorescent small molecules. The treatment involves contacting cancer cells with these molecules and directing near-IR light to induce the release of active platinum species and reactive oxygen species, effectively targeting and destroying cancer cells. He has 1 patent to his name.

Career Highlights

Mitra is affiliated with Virginia Commonwealth University, where he conducts his research. His work is characterized by a strong commitment to advancing cancer treatment methodologies. His innovative approach combines chemistry and biology to create effective therapeutic solutions.

Collaborations

Mitra collaborates with Matthew Hartman, contributing to the development of new cancer treatment strategies. Their partnership enhances the research output and fosters a collaborative environment for innovation.

Conclusion

Koushambi Mitra's contributions to cancer treatment through his patented innovations highlight the importance of research in developing effective therapies. His work exemplifies the potential of scientific advancements in improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…